CIK 0001585364
- Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +1 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- 4 Option exercise Director acquired 6,599 shares (option exercise)
- 4 Option exercise Director acquired 6,599 shares (option exercise)
- 4 Option exercise EVP, Chief Financial Officer acquired 3,963 shares (option exercise)
- 4 Open-market sale EVP and CIO sold 26,744 shares at an average $37.14 ($993,182)
- 4 Shares withheld for taxes EVP & CHRO gave up 5,209 shares (to pay taxes)
- 4 Open-market sale EVP, Gbl Ops & SC & CTO sold 3,954 shares at $36.73 ($145,232)
- 4 Grant or award EVP and CIO acquired 7,200 shares (grant or award)
- 4 Option exercise Director acquired 2,984 shares (option exercise)
- 4 Grant or award Executive VP, General Counsel acquired 14,503 shares (grant or award)
- 4 Grant or award EVP & President CSCA acquired 11,395 shares (grant or award)
- 4 Grant or award EVP, Chief Medical Officer acquired 6,008 shares (grant or award)
- 4 Grant or award CEO acquired 80,286 shares (grant or award)
- 4 Grant or award EVP, Chief Financial Officer acquired 19,422 shares (grant or award)
- 4 Grant or award EVP & President CHCI acquired 14,503 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Option exercise EVP & President CSCA acquired 4,297 shares (option exercise)
- 4 Open-market buy Executive VP, General Counsel bought 3,000 shares at $37.55 ($112,648)
- 4 Open-market buy Director bought 5,000 shares at $36.85 ($184,270)
- 4 Open-market buy Director bought 13,000 shares at $36.88 ($479,409)
- 4 Open-market buy EVP & President CHCI bought 3,655 shares at an average $37.10 ($135,599)
Page 13 of 41 · 805 filings